R. Parameswaran

Romiplostim for management of chemotherapy-induced thrombocytopenia

G. Schwartz, S. Devlin, M. Lunning, 2014, Supportive Care in Cancer.

Multiple myeloma and immune thrombocytopenia.

A. Newland, U. Hegde, V. Gupta, 2000, Clinical and laboratory haematology.

Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab

M. Perales, S. Devlin, A. Scaradavou, 2016, Bone Marrow Transplantation.

CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma

D. Samson, C. Giles, S. Kelsey, 2000, British journal of haematology.

Steroid Refractory Acute and Chronic Graft Versus Host Disease (GVHD) - Response to Photophoresis+/− Rituximab.

K. McCaul, R. Parameswaran, Maggie Sekeramayi, 2005 .

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo

N. Heisterkamp, J. Groffen, A. Yang, 2011, Blood cancer journal.

Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.

N. Munshi, J. Zonder, J. Drachman, 2009 .